These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21404136)

  • 81. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
    Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Apparent diffusion coefficient of glial neoplasms: correlation with fluorodeoxyglucose-positron-emission tomography and gadolinium-enhanced MR imaging.
    Holodny AI; Makeyev S; Beattie BJ; Riad S; Blasberg RG
    AJNR Am J Neuroradiol; 2010 Jun; 31(6):1042-8. PubMed ID: 20150307
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.
    O'Neill AF; Qin L; Wen PY; de Groot JF; Van den Abbeele AD; Yap JT
    J Neurooncol; 2016 Dec; 130(3):495-503. PubMed ID: 27576699
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Glioblastoma multiforme with diffusion-weighted magnetic resonance imaging characteristics mimicking primary brain lymphoma. Case report.
    Toh CH; Chen YL; Hsieh TC; Jung SM; Wong HF; Ng SH
    J Neurosurg; 2006 Jul; 105(1):132-5. PubMed ID: 16871888
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: comparison of three different ROI methods.
    Ahn SJ; Shin HJ; Chang JH; Lee SK
    PLoS One; 2014; 9(11):e112948. PubMed ID: 25393543
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quantitative biomarkers for liver metastases: comparison of MRI diffusion-weighted imaging heterogeneity index and fluorine-18-fluoro-deoxyglucose standardised uptake value in hybrid PET/MR.
    Stein D; Goldberg N; Domachevsky L; Bernstine H; Nidam M; Abadi-Korek I; Guindy M; Sosna J; Groshar D
    Clin Radiol; 2018 Sep; 73(9):832.e17-832.e22. PubMed ID: 29859634
    [TBL] [Abstract][Full Text] [Related]  

  • 88. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.
    Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I
    Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Glioblastoma multiforme with atypical diffusion-weighted MR findings.
    Hakyemez B; Erdogan C; Yildirim N; Parlak M
    Br J Radiol; 2005 Nov; 78(935):989-92. PubMed ID: 16249598
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
    Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM
    Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Role of glucose metabolism and cellularity for tumor malignancy evaluation using FDG-PET/CT and MRI.
    Tanimoto K; Yoshikawa K; Obata T; Ikehira H; Shiraishi T; Watanabe K; Saga T; Mizoe J; Kamada T; Kato A; Miyazaki M
    Nucl Med Commun; 2010 Jun; 31(6):604-9. PubMed ID: 20429097
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Diffusion-weighted magnetic resonance imaging in metastatic gastrointestinal stromal tumor (GIST): a pilot study on the assessment of treatment response in comparison with 18F-FDG PET/CT.
    Schmidt S; Dunet V; Koehli M; Montemurro M; Meuli R; Prior JO
    Acta Radiol; 2013 Oct; 54(8):837-42. PubMed ID: 23761549
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
    Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
    Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
    Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
    Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Primary brain lymphoma and glioblastoma: evaluation of DCE T1 and DSC T2 MRI perfusion findings.
    Soydan H; Sözmen Cılız D; Cesur T; Tezgör Aksakal E
    Acta Radiol; 2024 Jul; 65(7):800-807. PubMed ID: 38798137
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.
    Togao O; Chikui T; Tokumori K; Kami Y; Kikuchi K; Momosaka D; Kikuchi Y; Kuga D; Hata N; Mizoguchi M; Iihara K; Hiwatashi A
    PLoS One; 2020; 15(12):e0243839. PubMed ID: 33315914
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Differentiating Primary Central Nervous System Lymphomas From Glioblastomas and Inflammatory Demyelinating Pseudotumor Using Relative Minimum Apparent Diffusion Coefficients.
    Wen JB; Huang WY; Xu WX; Wu G; Geng DY; Yin B
    J Comput Assist Tomogr; 2017; 41(6):904-909. PubMed ID: 28708728
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
    Wang P; Shi YH; Li JY; Zhang CZ
    World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.
    Anwar SSM; Baig MZ; Laghari AA; Mubarak F; Shamim MS; Jilani UA; Khalid MU
    Neuroradiol J; 2019 Oct; 32(5):328-334. PubMed ID: 31188064
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings.
    Jain TK; Sharma P; Suman SK; Faizi NA; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2013; 32(6):394-6. PubMed ID: 23743243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.